Skip to main content

Advertisement

ADVERTISEMENT

News

News
04/14/2023
Class II recalls have been issued for multiple statins manufactured by two firms and distributed throughout the United States.
Class II recalls have been issued for multiple statins manufactured by two firms and distributed throughout the United States.
Class II recalls have been...
04/14/2023
Pharmacy Learning Network
News
04/14/2023
Teva Pharmaceuticals is voluntarily recalling a prescription drug used to control asthma and relieve symptoms of allergic rhinitis.
Teva Pharmaceuticals is voluntarily recalling a prescription drug used to control asthma and relieve symptoms of allergic rhinitis.
Teva Pharmaceuticals is...
04/14/2023
Pharmacy Learning Network

Advertisement

News
04/14/2023
A prescription medication used to treat anxiety and panic disorder is under a Class II recall due to cross contamination concerns.
A prescription medication used to treat anxiety and panic disorder is under a Class II recall due to cross contamination concerns.
A prescription medication used...
04/14/2023
Pharmacy Learning Network
News
03/09/2023
Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl, known by the branded name Altuviiio, is expected to hit the US market in April 2023.
Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl, known by the branded name Altuviiio, is expected to hit the US market in April 2023.
Antihemophilic factor...
03/09/2023
First Report Managed Care
News
03/09/2023
Researchers studied substance use disorder diagnoses in VA patients from fiscal years 2010 to 2019, identifying trends by type and number of diagnoses.
Researchers studied substance use disorder diagnoses in VA patients from fiscal years 2010 to 2019, identifying trends by type and number of diagnoses.
Researchers studied substance...
03/09/2023
Veterans Health Today

Advertisement

News
03/02/2023
A prescription drug used to treat hypothyroidism is under a Class I recall because the medication may be subpotent.
A prescription drug used to treat hypothyroidism is under a Class I recall because the medication may be subpotent.
A prescription drug used to...
03/02/2023
Pharmacy Learning Network
News
03/02/2023
More than 12,000 bottles of warfarin are being recalled for failing to meet testing specifications.
More than 12,000 bottles of warfarin are being recalled for failing to meet testing specifications.
More than 12,000 bottles of...
03/02/2023
Pharmacy Learning Network
News
02/23/2023
In a press release today, Humana shares intention to depart the employer group medical products business to focus on government-funded programs.
In a press release today, Humana shares intention to depart the employer group medical products business to focus on government-funded programs.
In a press release today, Humana...
02/23/2023
First Report Managed Care

Advertisement

News
02/22/2023
A study comparing dimethyl fumarate to placebo for patients with primary progressive multiple sclerosis yielded mixed results, prompting investigators to recommend more research.
A study comparing dimethyl fumarate to placebo for patients with primary progressive multiple sclerosis yielded mixed results, prompting investigators to recommend more research.
A study comparing dimethyl...
02/22/2023
First Report Managed Care
News
02/10/2023
Several sanitizing and disinfecting products are under a Class II recall for deviations from Current Good Manufacturing Practices.
Several sanitizing and disinfecting products are under a Class II recall for deviations from Current Good Manufacturing Practices.
Several sanitizing and...
02/10/2023
Pharmacy Learning Network

Advertisement